Cargando…
Rabeprazole sodium delayed-release multiparticulates: Effect of enteric coating layers on product performance
Rabeprazole sodium is one of the most effective proton pump inhibitors (PPIs) used in antiulcer therapy. Like most other PPIs, owing to its acid-labile nature, the drug is formulated as enteric-coated dosage form. Conventional means of producing delayed release multiparticulate dosage forms of PPIs...
Autores principales: | Tirpude, Rakesh N., Puranik, Prashant K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217710/ https://www.ncbi.nlm.nih.gov/pubmed/22171316 http://dx.doi.org/10.4103/2231-4040.85539 |
Ejemplares similares
-
Development and in vitro Evaluation of Enteric Coated Multiparticulate System for Resistant Tuberculosis
por: Rahman, Md. A., et al.
Publicado: (2008) -
Quality by Design Applied Development of Immediate-Release Rabeprazole Sodium Dry-Coated Tablet
por: Lee, Sang-Ho, et al.
Publicado: (2021) -
Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole
por: Bae, Sungyeun, et al.
Publicado: (2023) -
Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules
por: Tan, Yinhe, et al.
Publicado: (2016) -
Development of orally disintegrating tablets comprising controlled-release multiparticulate beads
por: Venkatesh, Gopi M., et al.
Publicado: (2012)